<DOC>
	<DOCNO>NCT00754065</DOCNO>
	<brief_summary>The objective study compare oral contraceptive ( OC ) SH T00658ID Ortho Tri-Cyclen Lo administer 13 cycle healthy female volunteer 18 50 year age request oral contraceptive protection . Subjects levonorgestrel ( LNG ) , norgestimate ( NGM ) , norethindrone norethindrone acetate contain oral contraceptive 21-day regimen suffer hormone withdrawal-associated symptom pelvic pain headache , willing continue OC use switch SH T00658ID Ortho Tri-Cyclen Lo .</brief_summary>
	<brief_title>To Compare SH T00658ID Over Ortho Tri-Cyclen Lo ( US/Canada )</brief_title>
	<detailed_description>Safety issue address Adverse Events section .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>Signed date informed consent Age 18 50 year ( inclusive ) , smoker maximum age 35 year ( inclusive ) Visit 1 Otherwise healthy female subject request contraception currently use LNG , NGM , norethindrone/norethindrone acetate contain OC 21day regimen suffer least moderate pelvic pain , headache define average high 3 value &gt; /=35 mm VAS cycle day 2228 ( 35 mm VAS expect standard deviation population VAS reduction ) Normal clinically insignificant cervical smear require follow ( cervical smear take screen visit normal result document within last 6 month screen ) Women atypical squamous cell undetermined significance ( ASCUS ) include negative human papilloma virus ( HPV ) test result . The laboratory perform HPV test Pap smear result ASCUS . Able tolerate ibuprofen willing use ibuprofen supply investigator Pregnancy lactation ( less three cycle since delivery , abortion , lactation start treatment ) Body mass index ( BMI ) &gt; 32 kg/m2 Hypersensitivity study drug ingredient Individuals willing consume pork beef product . Women may include willing take capsule Safety relevant laboratory value , provide central laboratory , outside inclusion range start treatment Any diseases condition compromise function body system could result altered absorption , excessive accumulation , impaired metabolism , alter excretion study medication ( limited duodenal ulcer , gastritis , gastrectomy gastric resection surgery , renal compromise ) Any disease condition might interfere conduct study interpretation result Any disease condition may worsen hormonal treatment Undiagnosed abnormal genital bleeding Abuse alcohol , drug , medicine ( eg , laxative ) Other contraceptive method Any medication could result excessive accumulation , impaired metabolism , alter excretion study drug interfere conduct study interpretation result Simultaneous participation another clinical trial prior study entry might impact study objective discretion investigator Major surgery schedule study period Subject dependent person , eg : family member member Investigator 's staff Inability cooperate study procedure reason , include language comprehension , psychiatric illness , inability get study site</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Oral contraceptive</keyword>
	<keyword>Estradiol valerate dienogest</keyword>
	<keyword>EV/DNG</keyword>
	<keyword>comparative tolerability</keyword>
</DOC>